Erode M D Chit Funds Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.50 M
- Revenue Growth 196.49%
- Profit Growth 172.30%
- Ebitda 17865.22%
- Net Worth
- Total Assets 70.63%
About Erode M D Chit Funds
Erode M D Chit Funds Private Limited (EMDCFPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2015 (Nine years and eight months 22 days old ). Its registered office is in Erode, Tamil Nadu, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.50 M.
Muthusamy Easwaran and Easwaran Chandra serve as directors at the Company.
Company Details
-
Location
Erode, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U65992TZ2015PTC021376
-
Company No.
021376
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 May 2015
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Erode M D Chit Funds?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthusamy Easwaran
|
Managing Director | 13-May-2015 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Easwaran Chandra
|
Director | 13-May-2015 | Current |
Financial Performance of Erode M D Chit Funds.
Erode M D Chit Funds Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 196.49% increase. The company also saw a substantial improvement in profitability, with a 172.3% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Erode M D Chit Funds?
In 2019, Erode M D Chit Funds had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2020 | Others | ₹2.50 M | Open |
How Many Employees Work at Erode M D Chit Funds?
Unlock and access historical data on people associated with Erode M D Chit Funds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Erode M D Chit Funds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erode M D Chit Funds's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.